Bioharvest sciences announces breakthrough in botanical synthesis capabilities with plant-based exosome production at scale

Exosomes produced in the liquid media of the bioharvest unique large-scale bioreactors add potential new revenue stream from products and cdmo opportunities rehovot, israel--(newsfile corp. - september 10, 2025) - bioharvest sciences inc. (nasdaq: bhst) (fse: 8mv0) ("bioharvest" or the "company"), a company pioneering its patented botanical synthesis technology platform, today announced that it has successfully produced, at scale, plant-based exosomes in its bioreactor media, marking a significant advancement in the company's proprietary botanical synthesis platform and in its ability to generate new revenue streams. exosomes are nano-sized extracellular vesicles naturally secreted by plant cells, with bioactive properties with enhanced absorption and bioavailability levels versus regular plant compounds.
BHST Ratings Summary
BHST Quant Ranking